Valuation: Boule Diagnostics AB

Market Cap 132M 13.91M 12.01M 11.26M 10.26M 19.29M 1.33B 19.56M 51.74M 666M 52.21M 51.08M 2.22B P/E 2026 *
-13.5x
P/E 2027 * 15.4x
Enterprise Value 329M 34.61M 29.88M 28.03M 25.53M 48M 3.31B 48.67M 129M 1.66B 130M 127M 5.51B EV / Sales 2026 *
0.73x
EV / Sales 2027 * 0.65x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 week-3.41%
Current month-10.99%
1 month-5.56%
3 months+3.03%
6 months-21.84%
Current year-30.75%
1 week 3.27
Extreme 3.27
3.61
1 month 3.24
Extreme 3.24
3.95
Current year 2.75
Extreme 2.75
5.68
1 year 2.75
Extreme 2.75
6.64
3 years 2.75
Extreme 2.75
12.62
5 years 2.75
Extreme 2.75
61.2
10 years 2.75
Extreme 2.75
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap.
27/02/23 Buy

Chief Financial Officer

8,000 0.0206%
06/02/23 Buy

Director

7,083 0.0182%
17/02/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+4.12%-3.41%-47.20%-64.06% 13.91M
-0.47%-2.36%+19.73%+9.25% 216B
+0.09%-3.22%-3.93%-19.85% 142B
-1.06%-0.78%-18.73%+34.56% 138B
-0.77%+1.92%-50.15%+0.96% 74.53B
-0.86%-1.33%+16.04%+18.20% 52.34B
+0.17%-1.34%-17.30%-14.17% 50.28B
-0.05%-0.18%+24.54%+22.84% 41.93B
-1.07%-0.98%+39.85%+49.27% 40.06B
-1.79%-0.78%-1.40%+5.82% 32.69B
Average -0.46%-1.03%-3.86%+4.28% 78.87B
Weighted average by Cap. -0.43%-1.16%-0.08%+9.35%

Financials

2026 *2027 *
Net sales 453M 47.73M 41.2M 38.65M 35.21M 66.2M 4.56B 67.12M 178M 2.29B 179M 175M 7.6B 483M 50.91M 43.95M 41.23M 37.55M 70.61M 4.87B 71.59M 189M 2.44B 191M 187M 8.11B
Net income -9.77M -1.03M -889K -834K -759K -1.43M -98.42M -1.45M -3.83M -49.31M -3.86M -3.78M -164M 8.6M 905K 782K 733K 668K 1.26M 86.57M 1.27M 3.37M 43.37M 3.4M 3.33M 144M
Net Debt 197M 20.7M 17.87M 16.77M 15.27M 28.71M 1.98B 29.11M 77.02M 992M 77.72M 76.04M 3.3B 185M 19.43M 16.78M 15.74M 14.34M 26.96M 1.86B 27.33M 72.31M 931M 72.96M 71.38M 3.1B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
18/08/26 SEK 3.400 0.00% 10
17/08/26 SEK 3.400 -2.30% 24,509
14/08/26 SEK 3.480 -3.60% 44,152
13/08/26 SEK 3.610 +3.14% 5,364
12/08/26 SEK 3.500 -0.57% 4,200
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.400SEK
Average target price
3.800SEK
Spread / Average Target
+11.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock